封面
市場調查報告書
商品編碼
1879920

全球血液凝固檢驗市場

Coagulation Testing

出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球血液凝固檢驗市場預計2030年將達到45億美元。

全球血液凝固檢驗市場規模在2024年估計為34億美元,預計2030年將達到45億美元,在分析期間(2024-2030年)內複合年成長率(CAGR)為4.8%。本報告分析的細分市場之一-血液凝固檢驗耗材,預計將以5.1%的複合年成長率成長,並在分析期間結束時達到37億美元。血液凝固檢驗設備細分市場預計在分析期間將以3.5%的複合年成長率成長。

美國市場規模估計為8.946億美元,而中國市場預計將以7.3%的複合年成長率成長。

據估計,2024年美國血液凝固檢驗市場規模將達8.946億美元。作為世界第二大經濟體,中國預計到2030年市場規模將達到9.9億美元,在2024年至2030年的分析期間內,複合年成長率(CAGR)將達到7.3%。其他值得關注的區域市場分析包括日本和加拿大,預計在分析期間內,這兩個國家的複合年成長率將分別達到2.4%和4.7%。在歐洲,德國預計將以約2.9%的複合年成長率成長。

全球血液凝固檢驗市場-主要趨勢與促進因素概述

為什麼血液凝固檢驗在現代醫學中至關重要

血液凝固檢驗在現代醫學中血液凝固檢驗至關重要的作用。這些檢查用於評估血液的正常凝固能力,對於診斷出血性疾病、監測抗凝血治療以及在手術過程中管理患者至關重要。正常的血液凝固對於預防過度出血至關重要,但凝血過程異常會導致嚴重的疾病,例如血栓症(過度凝血)和出血(凝血功能障礙)。血液凝固檢驗對​​於患有血友病和深層靜脈栓塞症(DVT)等疾病的患者,或服用Warfarin等抗凝血藥物的患者尤其重要。這些檢查,包括凝血酶原時間(PT)、活化部份凝血活酵素時間(aPTT)和國際標準化比值(INR),為醫生提供有關患者血液凝固能力的關鍵資訊,從而能夠及時診斷疾病並調整治療方案。如果沒有血液凝固檢驗,失控出血和凝血相關併發症的風險會顯著增加,尤其是在高風險族群中,例如接受手術的人、創傷患者和患有慢性心血管疾病的人。

血液凝固檢驗為何如此先進可靠?

血液凝固檢驗是一個高度專業化的領域,因為它涉及對血液凝固速度和效率的精確測量,且過程複雜。現代凝血分析儀相比傳統的手動方法有了顯著的改進,並融合了先進技術,從而提高了準確性和效率。這些設備利用光學、機械或電化學系統即時測量血塊的形成,提供快速可靠的結果。例如,光學方法檢測凝血過程中血漿濁度的變化,而機械系統則追蹤血塊的物理運動。現代系統可以同時處理多個檢測項目,並自動完成樣本製備和試劑處理等步驟,從而減少人為誤差,提高檢查室的檢測效率。除了硬體技術的進步外,試劑配方的創新也提高了血液凝固檢驗的敏感度和特異性。這使得檢測凝血功能中細微的異常成為可能,這對於疑似患有輕度或早期凝血障礙的患者尤其重要。一些先進的分析儀還具備就地檢驗功能,使醫護人員能夠在檢查室外進行血液凝固檢驗,例如在急診室或長期接受抗凝血治療的患者就診期間。儀器和試劑化學的這些進步提高了血液凝固檢驗的可靠性,為醫護人員提供了所需的精準度和效率,使他們能夠自信地管理危重病患的病情。

在現代醫學發展趨勢的背景下,血液凝固檢驗正在發生怎樣的變化?

為了應對日益成長的醫療需求和技術進步,血液凝固檢驗領域正在迅速發展。其中一個最顯著的趨勢是向照護現場(POC​​)的轉變,這種檢測方式無需在傳統檢查室環境下即可提供即時結果。這對於服用Warfarin等抗凝血藥物的患者管理尤其重要,因為這類藥物需要定期監測以調整劑量並避免併發症。攜帶式凝血分析儀使醫護人員能夠在診所、家中甚至偏遠地區進行檢測,從而改善患者就醫途徑並減少就醫次數。這一趨勢與「個人化醫療」的理念相契合,後者旨在提供根據個別患者需求量身定做的醫療服務,而即時檢測使這種方法更具可行性。另一個發展領域是將數位技術和數據分析融入血液凝固檢驗。許多現代分析儀都配備了軟體,可以追蹤患者的檢測結果隨時間的變化,提醒患者凝血活性發生顯著變化,並為臨床醫生產生詳細的報告。機器學習和人工智慧 (AI) 的應用也開始在血液凝固檢驗中發揮作用,AI 演算法能夠根據檢測結果、既往病歷和其他健康數據預測患者預後。此外,新型生物標記和新一代試劑的開發,正在拓展血液凝固檢驗的範圍,使其超越標準的 PT/INR 和 aPTT 檢測。這些新檢測方法能夠更深入了解凝血途徑,幫助醫生診斷瀰漫性血管內凝血 (DIC) 等複雜疾病,並監測新型抗凝血療法(例如直介面服抗凝血劑 (DOAC))的療效。

哪些因素正在推動血液凝固檢驗市場的成長?

血液凝固檢驗市場的成長受多種因素驅動。其中一個關鍵促進因素是全球心血管疾病盛行率的不斷上升。這使得定期監測血液凝固功能變得特別重要,特別是對於有血栓症風險的患者以及接受抗凝血治療的患者。隨著中風、心肌梗塞和心房顫動等心血管疾病的日益普遍,對血液凝固檢驗的需求呈指數級成長。全球人口老化也是市場成長的重要因素。老年人更容易患有凝血功能障礙,因此需要定期進行靜脈血栓栓塞症(VTE) 等疾病的檢測,並進行抗凝血治療管理。這種人口結構的變化正在持續推動對檢查室檢測和照護現場(POC)血液凝固檢驗解決方案的需求。此外,直介面服抗凝血劑 (DOAC) 的快速發展也擴大了凝血監測的範圍。門診診所和居家醫療服務的興起進一步推動了對攜帶式、易用型血液凝固檢驗設備的需求。由於其便利性和快速出結果的特性,就地檢驗在接受長期抗凝血治療的患者中越來越受歡迎,而快速出結果對於調整藥物劑量至關重要。另一個關鍵的成長要素是醫療基礎設施投資的增加,尤其是在新興市場。隨著這些地區醫療體系的發展,對包括凝血分析儀在內的先進診斷工具的需求日益成長。各國政府和醫療機構正在投資建造最先進的檢查室和診斷中心,以擴大醫療服務不足地區血液凝固檢驗的覆蓋範圍。最後,自動化、人工智慧整合和即時數據分析等技術進步正在提高血液凝固檢驗的準確性和速度。這些因素共同推動了血液凝固檢驗市場的成長,使其成為全球醫療保健體系中的關鍵組成部分。

部分:

產品(耗材、設備)、測試類型(能力驗證、其他測試類型)、最終用途(醫院/診所、診斷檢查室、居家醫療環境、其他最終用途)

受訪公司範例

  • Abbott Laboratories, Inc.
  • Agappe Diagnostics Ltd.
  • Alere, Inc.
  • F. Hoffmann-La Roche AG
  • Helena Laboratories, Inc.
  • HemoSonics, LLC
  • Horiba, Ltd.
  • Medtronic PLC
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Universal Biosensors Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具,改變您分析市場和競爭情報的方式。

Market Glass, Inc. 沒有採用查詢LLM 或產業專用的SLM 的常見做法,而是建立了一個由世界各地領域專家精心策劃的內容庫,其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中,Market Glass, Inc. 將關稅對地理市場的影響納入考量,並根據公司總部所在地、製造地以及進出口(成品和OEM產品)情況,預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手,包括增加銷貨成本、降低盈利和重組供應鏈,同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP11116

Global Coagulation Testing Market to Reach US$4.5 Billion by 2030

The global market for Coagulation Testing estimated at US$3.4 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Coagulation Testing Instruments segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$894.6 Million While China is Forecast to Grow at 7.3% CAGR

The Coagulation Testing market in the U.S. is estimated at US$894.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$990.0 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Coagulation Testing Market - Key Trends and Drivers Summarized

Why Is Coagulation Testing Essential in Modern Healthcare?

Coagulation testing plays a crucial role in modern healthcare. Coagulation tests are used to assess the blood's ability to clot properly and are critical for diagnosing bleeding disorders, monitoring anticoagulant therapy, and managing patients during surgical procedures. Proper blood clotting is essential for preventing excessive bleeding, but abnormalities in this process can lead to serious conditions such as thrombosis (excessive clotting) or hemorrhage (inability to clot). Coagulation tests are particularly important for patients with conditions like hemophilia, deep vein thrombosis (DVT), or those taking blood-thinning medications like warfarin. These tests, including prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR), provide doctors with critical information about how well a patient’s blood coagulates, allowing for the timely diagnosis of disorders and adjustments in treatment plans. Without coagulation testing, the risk of uncontrolled bleeding or clotting-related complications would significantly increase, especially in high-risk populations such as those undergoing surgery, trauma victims, or patients with chronic cardiovascular diseases.

What Makes Coagulation Testing So Advanced and Reliable?

Coagulation testing is highly specialized due to the precision and complexity involved in measuring how quickly and efficiently blood clots. Modern coagulation analyzers have evolved significantly from traditional manual methods, incorporating advanced technologies that enhance both accuracy and efficiency. These devices use optical, mechanical, or electrochemical systems to measure clot formation in real-time, providing quick and reliable results. Optical methods, for example, detect changes in the turbidity of plasma as the clot forms, while mechanical systems track the physical movement of clots. Modern systems are also capable of handling multiple tests at once, automating processes such as sample preparation and reagent handling, thereby reducing human error and increasing throughput in laboratories. In addition to technological advancements in the hardware, innovations in reagent formulation have improved the sensitivity and specificity of coagulation tests. This ensures that even slight abnormalities in clotting can be detected, which is particularly important in patients who may have subtle or early-stage coagulation disorders. Some advanced analyzers are also equipped with point-of-care testing capabilities, allowing healthcare providers to perform coagulation tests outside the laboratory setting, such as in emergency rooms or during home visits for patients on long-term anticoagulation therapy. These advancements in both instrumentation and reagent chemistry make coagulation testing more reliable, offering healthcare providers the accuracy and efficiency needed to manage critical patient conditions with confidence.

How Is Coagulation Testing Evolving With Modern Healthcare Trends?

The landscape of coagulation testing is evolving rapidly in response to growing healthcare needs and technological advancements. One of the most significant trends is the shift toward point-of-care (POC) testing, which allows for immediate results outside traditional laboratory settings. This is particularly beneficial for managing patients on anticoagulants, such as warfarin, where regular monitoring is required to adjust dosages and avoid complications. Portable coagulation analyzers now allow healthcare providers to conduct these tests in clinics, at home, or even in remote locations, improving patient access to care and reducing the need for frequent hospital visits. This trend is aligned with the broader movement toward personalized medicine, where care is tailored to the individual patient’s needs, and POC testing helps make this approach more feasible. Another area of evolution is the integration of digital technologies and data analytics into coagulation testing. Many modern analyzers are equipped with software that can track patient results over time, flagging any significant changes in clotting ability and generating detailed reports for clinicians. The use of machine learning and artificial intelligence (AI) is also beginning to play a role in coagulation testing, with AI-powered algorithms helping to predict patient outcomes based on test results, past medical history, and other health data. Additionally, the development of novel biomarkers and next-generation reagents is expanding the scope of coagulation tests beyond standard PT/INR and aPTT measurements. These emerging tests provide deeper insights into coagulation pathways, helping physicians diagnose complex disorders such as disseminated intravascular coagulation (DIC) or monitor the effects of newer anticoagulant therapies like direct oral anticoagulants (DOACs).

What Is Driving the Growth of the Coagulation Testing Market?

The growth in the coagulation testing market is driven by several factors. One of the primary drivers is the increasing global prevalence of cardiovascular diseases, which necessitates regular monitoring of blood coagulation, particularly in patients at risk of thrombosis or those receiving anticoagulant therapy. As cardiovascular conditions such as stroke, heart attack, and atrial fibrillation become more common, the demand for coagulation testing is rising sharply. The aging global population is also a major contributor to market growth, as older adults are more likely to suffer from clotting disorders and require routine testing for conditions like venous thromboembolism (VTE) or to manage anticoagulant therapies. This demographic shift is creating a sustained demand for both laboratory-based and point-of-care coagulation testing solutions. Additionally, the rapid development of direct oral anticoagulants (DOACs) has expanded the scope of coagulation monitoring. The rise in outpatient care and home healthcare services is further driving the demand for portable and easy-to-use coagulation testing devices. Point-of-care testing is becoming increasingly popular among patients on long-term anticoagulation therapy, as it offers convenience and timely results, which are critical for adjusting medication dosages. Another significant growth driver is the increasing investment in healthcare infrastructure, particularly in emerging markets. As these regions develop their healthcare systems, the demand for sophisticated diagnostic tools, including coagulation analyzers, is rising. Governments and healthcare organizations are investing in state-of-the-art laboratories and diagnostic centers, expanding access to coagulation testing in underserved areas. Finally, technological advancements, including automation, AI integration, and real-time data analytics, are enhancing the accuracy and speed of coagulation testing. These combined factors are fueling the growth of the coagulation testing market, making it a vital component of the global healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Coagulation Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instruments); Test Type (PT, Other Test Types); End-Use (Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 38 Featured) -

  • Abbott Laboratories, Inc.
  • Agappe Diagnostics Ltd.
  • Alere, Inc.
  • F. Hoffmann-La Roche AG
  • Helena Laboratories, Inc.
  • HemoSonics, LLC
  • Horiba, Ltd.
  • Medtronic PLC
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Universal Biosensors Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Coagulation Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Cardiovascular Disorders Spurs Demand for Coagulation Testing
    • Aging Population Drives Growth in Coagulation Testing for Chronic Disease Management
    • Rising Adoption of Point-of-Care Testing (POCT) Expands the Addressable Market for Coagulation Testing Devices
    • Technological Innovations in Automated Coagulation Analyzers Propel Market Growth
    • Personalized Medicine and Precision Healthcare Strengthen the Business Case for Advanced Coagulation Testing
    • Here's How Direct Oral Anticoagulants (DOACs) Drive the Need for Specialized Coagulation Testing
    • Increasing Prevalence of Venous Thromboembolism (VTE) Accelerates Demand for Coagulation Screening
    • Expanding Global Healthcare Access in Emerging Economies Expands Market Opportunities for Coagulation Testing
    • Growing Awareness of Bleeding Disorders and Early Diagnosis Initiatives Drives Market Adoption of Coagulation Tests
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Coagulation Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Coagulation Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for PT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for PT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for PT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Coagulation Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Coagulation Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Coagulation Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Coagulation Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION